Mitchell Sinkler & Starr’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-4,658
| Closed | -$207K | – | 89 |
|
|
2017
Q4 | $207K | Sell |
4,658
-1,200
| -20% | -$53.3K | 0.31% | 79 |
|
|
2017
Q3 | $297K | Buy |
5,858
+800
| +16% | +$40.6K | 0.47% | 67 |
|
|
2017
Q2 | $273K | Buy |
5,058
+80
| +2% | +$4.32K | 0.45% | 68 |
|
|
2017
Q1 | $262K | Sell |
4,978
-3,520
| -41% | -$185K | 0.43% | 70 |
|
|
2016
Q4 | $409K | Sell |
8,498
-728
| -8% | -$35K | 0.57% | 58 |
|
|
2016
Q3 | $497K | Hold |
9,226
| – | – | 0.78% | 43 |
|
|
2016
Q2 | $500K | Sell |
9,226
-720
| -7% | -$39K | 0.68% | 48 |
|
|
2016
Q1 | $504K | Hold |
9,946
| – | – | 0.7% | 48 |
|
|
2015
Q4 | $502K | Sell |
9,946
-2,400
| -19% | -$121K | 0.69% | 48 |
|
|
2015
Q3 | $593K | Hold |
12,346
| – | – | 0.76% | 42 |
|
|
2015
Q2 | $643K | Buy |
12,346
+188
| +2% | +$9.79K | 0.76% | 43 |
|
|
2015
Q1 | $701K | Hold |
12,158
| – | – | 0.79% | 43 |
|
|
2014
Q4 | $650K | Hold |
12,158
| – | – | 0.73% | 47 |
|
|
2014
Q3 | $699K | Sell |
12,158
-400
| -3% | -$23K | 0.78% | 43 |
|
|
2014
Q2 | $840K | Hold |
12,558
| – | – | 0.9% | 38 |
|
|
2014
Q1 | $839K | Hold |
12,558
| – | – | 0.94% | 38 |
|
|
2013
Q4 | $838K | Sell |
12,558
-2,366
| -16% | -$158K | 0.94% | 39 |
|
|
2013
Q3 | $936K | Sell |
14,924
-4,012
| -21% | -$252K | 1.07% | 37 |
|
|
2013
Q2 | $1.18M | Buy |
+18,936
| New | +$1.18M | 0.26% | 74 |
|